{
    "root": "3003e550-5f72-131f-e063-6294a90a13e2",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Travoprost",
    "value": "20250310",
    "ingredients": [
        {
            "name": "PEG-40 CASTOR OIL",
            "code": "4ERD2076EF",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_140618"
        },
        {
            "name": "BORIC ACID",
            "code": "R57ZHV85D4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_33118"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SORBITOL",
            "code": "506T60A25R",
            "drugbank_id": "https://go.drugbank.com/drugs/DB01638"
        },
        {
            "name": "ZINC CHLORIDE",
            "code": "86Q357L16B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17996"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32145"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_37527"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_15377"
        },
        {
            "name": "TRAVOPROST",
            "code": "WJ68R08KX9",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_746859"
        }
    ],
    "indications": {
        "text": "travoprost ophthalmic solution ( ionic buffered solution ) 0.004 % indicated reduction elevated intraocular pressure ( iop ) patients open angle glaucoma ocular hypertension .",
        "doid_entities": [
            {
                "text": "open angle glaucoma (DOID:1067)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1067"
            },
            {
                "text": "glaucoma (DOID:1686)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1686"
            },
            {
                "text": "ocular hypertension (DOID:9282)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_9282"
            },
            {
                "text": "hypertension (DOID:10763)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_10763"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "recommended one drop affected eye ( ) daily evening . travoprost ophthalmic solution ( ionic buffered solution ) administered daily since shown frequent prostaglandin analogs may decrease iop lowering effect . reduction iop starts approximately 2 hours first maximum effect reached 12 hours . travoprost ophthalmic solution ( ionic buffered solution ) may used concomitantly topical ophthalmic products lower intraocular pressure ( iop ) . one topical ophthalmic used , drugs administered least five ( 5 ) minutes apart .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "travoprost ophthalmic solution , usp ( ionic buffered solution ) 0.004 % sterile , isotonic , buffered , preserved , aqueous solution travoprost ( 0.04 mg/ml ) . travoprost ophthalmic solution , usp ( ionic buffered solution ) 0.004 % supplied 2.5 ml solution 5 ml solution 5 ml translucent polypropylene ophthalmic bottle translucent polypropylene ophthalmic dropper turquoise , opaque polypropylene cap . 2.5 ml fill ndc 51407-731-25 5 ml fill ndc 51407-731-05 storage : store 2\u00b0c 25\u00b0c ( 36\u00b0f 77\u00b0f ) . opening , travoprost ophthalmic solution , usp ( ionic buffered solution ) 0.004 % used expiration date bottle .",
    "adverseReactions": "none",
    "indications_original": "Travoprost ophthalmic solution (ionic buffered solution) 0.004% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma or ocular hypertension.",
    "contraindications_original": "The recommended dosage is one drop in the affected eye(s) once daily in the evening.\n \n  \n                        \n                     Travoprost ophthalmic solution (ionic buffered solution) should not be administered more than once daily since it has been shown that more frequent administration of prostaglandin analogs may decrease the IOP lowering effect.\n\n \n                  Reduction of the IOP starts approximately 2 hours after the first administration with maximum effect reached after 12 hours.\n                  Travoprost\n \n  ophthalmic solution (ionic buffered solution) may be used concomitantly with other topical ophthalmic drug products to lower intraocular pressure (IOP). If more than one topical ophthalmic drug is being used, the drugs should be administered at least five (5) minutes apart.",
    "warningsAndPrecautions_original": "Travoprost ophthalmic solution, USP (ionic buffered solution) 0.004% is a sterile, isotonic, buffered, preserved, aqueous solution of travoprost (0.04 mg/mL).  \n                  Travoprost ophthalmic solution, USP (ionic buffered solution) 0.004% is supplied as a 2.5 mL solution and a 5 mL solution in a 5 mL translucent polypropylene ophthalmic bottle with a translucent polypropylene ophthalmic dropper and a turquoise, opaque polypropylene cap.\n                  2.5 mL fill           NDC 51407-731-25\n                  5 mL fill              NDC 51407-731-05\n                  \n                     Storage:\n                     Store at 2\u00b0C to 25\u00b0C (36\u00b0F to 77\u00b0F).\n                  \n                  After opening, travoprost ophthalmic solution, USP (ionic buffered solution) 0.004% can be used until the expiration date on the bottle.",
    "adverseReactions_original": "None",
    "drug": [
        {
            "name": "Travoprost",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_746859"
        }
    ]
}